3B Pharmaceuticals is owned by its founders and senior management.
Looking forward, the company is open to further broaden its technology base and project portfolio, thereby providing an attractive entry for dedicated investors. We will carefully consider third party proposals which add value to the business of 3BP. Inquiries can be directed to

Promising development candidates. Peptides for healthcare applications.